In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
According to a Kaiser Permanente study, the rate of recommended vaccine doses administered to children has dramatically decreased since the outbreak of COVID-19.
Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.
Scientists from the University of Manchester have discovered an alteration in the immune system of COVID-19 patients 6 months after hospitalisation, which could be linked to poorer health outcomes.
Christine Hancock, Founder and Director at C3 Collaborating for Health, discusses the ongoing issue of health inequality that COVID-19 has exposed, and how to ensure healthy lives for all.
Open Access Government discuss how the Norwegian Minister for Health and Care Services, Bent Høie has navigated his ministries response to the COVID-19 crisis, and his priorities for 2021.
Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.
According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.
A new study by Washington University School of Medicine suggests that breastfeeding mothers may pass protective COVID-19 antibodies to their babies through breast milk for at least 80 days following vaccination.
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
Open Access Government discusses the importance of funding visionaries, explorers and innovators who are searching for scientific and technical breakthroughs in Canada.
Open Access Government explores the health priorities of Stella Kyriakides, Commissioner for Health and Food Safety, asking if lessons learned from the ongoing COVID-19 pandemic can help to improve European healthcare?.
We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
